Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Cancer Research

• Publication date

  2001-09-15

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 11559546
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Type 1 IGF receptor in human breast diseases

  2005cited by this paper
• Function of the IGF-I Receptor in Breast Cancer

  2004cited by this paper
• IGF-I: An Essential Factor in Terminal End Bud Formation and Ductal Morphogenesis

  2004cited by this paper
• Insulin-Like Growth Factor I-Induced Degradation of Insulin Receptor Substrate 1 Is Mediated by the 26S Proteasome and Blocked by Phosphatidylinositol 3′-Kinase Inhibition

  2000cited by this paper
• The PI3K-PDK1 connection: more than just a road to PKB.

  2000cited by this paper
• Down‐regulation of insulin‐like growth factor‐I receptor and insulin receptor substrate‐1 expression in advanced human breast cancer

  2000cited by this paper
• Urokinase Plasminogen Activator/Urokinase-specific Surface Receptor Expression and Matrix Invasion by Breast Cancer Cells Requires Constitutive p38α Mitogen-activated Protein Kinase Activity*

  2000cited by this paper
• Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt.

  1999cited by this paper
• AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation.

  1999influential reference
• SHC-alpha5beta1 integrin interactions regulate breast cancer cell adhesion and motility.

  1999cited by this paper
• p38 mitogen-activated protein kinase inhibitors--mechanisms and therapeutic potentials.

  1999influential reference
• The activated insulin-like growth factor I receptor induces depolarization in breast epithelial cells characterized by actin filament disassembly and tyrosine dephosphorylation of FAK, Cas, and paxillin.

  1999cited by this paper
• Multiple Signaling Pathways of the Insulin-Like Growth Factor 1 Receptor in Protection from Apoptosis

  1999cited by this paper
• Prolonged activation of ERK2 by epidermal growth factor and other growth factors requires a functional insulin-like growth factor 1 receptor.

  1999cited by this paper
• Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo.

  1999cited by this paper
• Insulin‐like growth factor (IGF)‐I rescues breast cancer cells from chemotherapy‐induced cell death – proliferative and anti‐apoptotic effects

  1999cited by this paper
• Phosphorylation and regulation of Raf by Akt (protein kinase B).

  1999cited by this paper
• SHC–α5β1 Integrin Interactions Regulate Breast Cancer Cell Adhesion and Motility

  1999cited by this paper
• IRS-1 expression and activation are not sufficient to activate downstream pathways and enable IGF-I growth response in estrogen receptor negative breast cancer cells.

  1999cited by this paper
• Epidermal growth factor promotes MDA-MB-231 breast cancer cell migration through a phosphatidylinositol 3'-kinase and phospholipase C-dependent mechanism.

  1999cited by this paper
• The IGF-I receptor in cancer research.

  1999cited by this paper
• Elevated insulin-like growth factor I receptor autophosphorylation and kinase activity in human breast cancer.

  1998cited by this paper
• A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer.

  1998cited by this paper
• Insulin Receptor Substrate-1 is the Predominant Signaling Molecule Activated by Insulin-like Growth Factor-I, Insulin, and Interleukin-4 in Estrogen Receptor-positive Human Breast Cancer Cells*

  1998cited by this paper
• Circulating concentrations of insulin-like growth factor-I and risk of breast cancer.

  1998cited by this paper
• Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase*

  1998cited by this paper
• Molecular markers of IGF-I-mediated mitogenesis.

  1998cited by this paper
• Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling.

  1998cited by this paper
• The IRS-signalling system: A network of docking proteins that mediate insulin action

  1998cited by this paper
• Differential roles of IRS‐1 and SHC signaling pathways in breast cancer cells

  1997influential reference
• Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation.

  1997cited by this paper
• Insulin-like growth factor 1 (IGF-1) alters drug sensitivity of HBL100 human breast cancer cells by inhibition of apoptosis induced by diverse anticancer drugs.

  1997cited by this paper
• Insulin-like growth factor binding protein-3 and insulin receptor substrate-1 in breast cancer: correlation with clinical parameters and disease-free survival.

  1997cited by this paper
• Overexpressed IGF-I receptors reduce estrogen growth requirements, enhance survival, and promote E-cadherin-mediated cell-cell adhesion in human breast cancer cells.

  1997cited by this paper
• Mitogenic Signaling of Insulin-like Growth Factor I in MCF-7 Human Breast Cancer Cells Requires Phosphatidylinositol 3-Kinase and Is Independent of Mitogen-activated Protein Kinase*

  1997cited by this paper
• Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.

  1997cited by this paper
• The IGF-I receptor in mitogenesis and transformation of mouse embryo cells: role of receptor number.

  1997cited by this paper
• The Roles of Integrins and Extracellular Matrix Proteins in the Insulin-like Growth Factor I-stimulated Chemotaxis of Human Breast Cancer Cells (*)

  1996cited by this paper
• Insulin‐like Growth Factor‐I (IGF‐I) Receptors in Breast Cancer

  1996cited by this paper
• Overexpression of insulin receptor substrate 1 (IRS-1) in the human breast cancer cell line MCF-7 induces loss of estrogen requirements for growth and transformation.

  1995cited by this paper
• Growth inhibition of MCF-7 breast cancer cells by stable expression of an insulin-like growth factor I receptor antisense ribonucleic acid.

  1995cited by this paper
• A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002).

  1994cited by this paper
• The prognostic value of insulin-like growth factor-I in breast cancer patients. Results of a follow-up study on 126 patients.

  1994cited by this paper
• Insulin and insulin-like growth factor signaling are defective in the MDA MB-468 human breast cancer cell line.

  1994cited by this paper
• Insulin-resistant MDA-MB231 human breast cancer cells contain a tyrosine kinase inhibiting activity.

  1993cited by this paper
• The response of breast cancer cells to steroid and peptide growth factors.

  1992cited by this paper
• Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice.

  1989cited by this paper
• Characterization of insulin-like growth factor 1 receptors (IGF1-R) in human breast cancer cell lines.

  1989cited by this paper

• Stress-Inducible Transcription Factor NUPR1 Is Involved in the Inhibitory Effects Exerted by Statins on Insulin Action in ER-Positive Breast Cancer Cells

  2026cites this paper
• Breast Cancer Cell Line-Specific Responses to Insulin: Effects on Proliferation and Migration

  2025cites this paper
• Impact of Dairy and Plant-Based Milk Products on the Growth Dynamics of Triple- Negative Breast Cancer Cells in Vitro

  2025cites this paper
• Antitumor Mechanisms of Lycium barbarum Fruit: An Overview of In Vitro and In Vivo Potential

  2024cites this paper
• Chemical profiling of volatile compounds of the essential oil of grey-leaved rockrose (Cistus albidus L.) and its antioxidant, anti-inflammatory, antibacterial, antifungal, and anticancer activity in vitro and in silico

  2024cites this paper
• Bitter melon extract suppresses metastatic breast cancer cells (MCF-7 cells) growth possibly by hindering glucose uptake

  2023cites this paper
• Association between prediabetes and breast cancer: a comprehensive meta-analysis

  2023cites this paper
• Evaluation of Antioxidant Activity, Cytotoxicity, and Genotoxicity of Ptychotis verticillata Essential Oil: Towards Novel Breast Cancer Therapeutics

  2023cites this paper
• Genetically predicted high IGF-1 levels showed protective effects on COVID-19 susceptibility and hospitalization: a Mendelian randomisation study with data from 60 studies across 25 countries

  2022cites this paper
• IGF-I induces upregulation of DDR1 collagen receptor in breast IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway. pathway.

  2022cites this paper
• Dual Characters of GH-IGF1 Signaling Pathways in Radiotherapy and Post-radiotherapy Repair of Cancers

  2021cites this paper
• Regulation of mRNA Translation by Hormone Receptors in Breast and Prostate Cancer

  2021cites this paper
• Daptomycin suppresses tumor migration and angiogenesis via binding to ribosomal protein S19 in humans

  2021cites this paper
• Tamoxifen/raloxifene loaded liposomes for oral treatment of breast cancer

  2020cites this paper
• Biological Activities and GCMS Analysis of the Methanolic Extract of Christia vespertilionis (L.F.) Bakh. F. Leaves

  2020cites this paper
• LINC00473 mediates cyclin D1 expression through a balance between activation and repression signals in breast cancer cells

  2019cites this paper
• Overexpression of Insulin Receptor Substrate 1 (IRS1) Promotes Radioresistance in A172 Glioblastoma Cell Line

  2019cites this paper
• RSK4 inhibits breast cancer cell proliferation and invasion in vitro, and is correlated with estrogen receptor upregulation in breast cancer.

  2019cites this paper
• The Role of Tumor and Tumor Microenvironment on Breast Cancer-Associated Adipocyte Plasticity

  2019cites this paper
• Self‐assembly of lipid rafts revealed by fluorescence correlation spectroscopy in living breast cancer cells

  2019cites this paper
• The rhenium(I)-diselenoether anticancer drug targets ROS, TGF-β1, VEGF-A, and IGF-1 in an in vitro experimental model of triple-negative breast cancers

  2019cites this paper
• Design of Rhenium Compounds in Targeted Anticancer Therapeutics.

  2019cites this paper
• Self-Assembly, Tunable Hydrogel Properties, and Selective Anti-Cancer Activity of a Carnosine-Derived Lipidated Peptide

  2019cites this paper
• Exploring the Pharmacological Mechanism of Danzhi Xiaoyao Powder on ER-Positive Breast Cancer by a Network Pharmacology Approach

  2018cites this paper
• Aiming for the Insulin-like Growth Factor-1 system in breast cancer therapeutics.

  2018cites this paper
• The expression of insulin receptor substrate 1 and estrogen receptor as prognostic factor on breast cancer patient

  2018cites this paper
• SOX9/FXYD3/Src Axis Is Critical for ER+ Breast Cancer Stem Cell Function

  2018cites this paper
• ROBO4 dans les cellules métastatiques du cancer du sein : identification et caractérisation fonctionnelle d’isoformes protéiques

  2017cites this paper
• Cytotoxic effects of seven Tunisian hospital wastewaters on the proliferation of human breast cancer cell line MDA-231: correlation with their chemical characterization

  2017influential citation
• Insulin‐like growth factor‐1 signaling is responsible for cathepsin G‐induced aggregation of breast cancer MCF‐7 cells

  2017cites this paper
• Insulin in combination with cisplatin induces the apoptosis of ovarian cancer cells via p53 and JNK activation.

  2017cites this paper
• Prognostic value of vitamin D receptor and insulin-like growth factor receptor 1 expression in triple-negative breast cancer

  2017cites this paper
• Binding of anterior gradient 2 and estrogen receptor-α: Dual critical roles in enhancing fulvestrant resistance and IGF-1-induced tumorigenesis of breast cancer.

  2016cites this paper
• Activation of GPER suppresses epithelial mesenchymal transition of triple negative breast cancer cells via NF‐κB signals

  2016cites this paper
• High and low dose radiation effects on mammary adenocarcinoma cells – an epigenetic connection

  2016cites this paper
• The Role of mTOR Inhibitors in Breast Cancer

  2016cites this paper
• Importance of different growth factors in oestrogen receptor-negative breast cancer

  2015cites this paper
• Tumor Suppressor Activity of Klotho in Breast Cancer Is Revealed by Structure–Function Analysis

  2015cites this paper
• Cloning and expression of full-length human insulin-like growth factor binding protein 3 (IGFBP3) in the Escherichia coli

  2015cites this paper
• The involvement of survivin in insulin-like growth factor 1-induced epithelial-mesenchymal transition in gastric cancer

  2015cites this paper
• IGF-1 from adipose-derived mesenchymal stem cells promotes radioresistance of breast cancer cells.

  2015cites this paper
• Enhancement effect of resveratrol on the intestinal absorption of bestatin by regulating PEPT1, MDR1 and MRP2 in vivo and in vitro.

  2015cites this paper
• IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway

  2015cites this paper
• EIF5A2 is a novel chemoresistance gene in breast cancer

  2015cites this paper
• Klotho structure-function relationships in breast cancer

  2015cites this paper
• The impact of IGF-1R expression on the outcomes of patients with breast cancer: a meta-analysis

  2015cites this paper
• Identifying the molecular mediators of VN and the IGF:VN complex-stimulated breast cancer cell survival

  2015cites this paper
• The impact of igF-1 r expression on the outcomes of patients with breast cancer : a meta-analysis

  2015cites this paper
• Thymoquinone-Loaded Nanostructured Lipid Carrier Exhibited Cytotoxicity towards Breast Cancer Cell Lines (MDA-MB-231 and MCF-7) and Cervical Cancer Cell Lines (HeLa and SiHa)

  2015cites this paper
• FAK activation is required for IGF1R-mediated regulation of EMT, migration, and invasion in mesenchymal triple negative breast cancer cells

  2015cites this paper
• MetastasisPromotes Mammary Tumor Suppression of Insulin Receptor Substrate

  2014cites this paper
• Body mass index, diabetes, and triple-negative breast cancer prognosis

  2014cites this paper
• The insulin-like growth factor 1 axis in prognosis and treatment of breast cancer

  2014cites this paper
• Genetics and epigenetics of direct and indirect radiation responses in normal mammary and breast cancer cells

  2014cites this paper
• GPER Mediates Estrogen-Induced Signaling and Proliferation in Human Breast Epithelial Cells and Normal and Malignant Breast

  2014cites this paper
• The lipid-transfer protein Nir2 enhances epithelial-mesenchymal transition and facilitates breast cancer metastasis

  2014cites this paper
• Luteolin Supplementation Modulates Mammary Tumor Growth in C3H Mice Fed Diet with High- and Low-Fat Content

  2014cites this paper
• Antitumoral and MMP-2 inhibition activity of raloxifene or tamoxifen loaded nanoparticles containing dimethyl-β-cyclodextrin

  2014cites this paper
• Mechanistic Analysis of Differential SignalTransduction Mediated by the Insulin ReceptorSubstrate Proteins IRS-1 and IRS-2: A Dissertation

  2014cites this paper
• MicroRNA-21 Promotes Glioblastoma Tumorigenesis by Down-regulating Insulin-like Growth Factor-binding Protein-3 (IGFBP3)*

  2014cites this paper
• Observations on the effects of Suppressor of Cytokine Signaling 7 (SOCS7) knockdown in breast cancer cells: their in vitro response to Insulin Like Growth Factor I (IGF-I)

  2014cites this paper
• IGF1 Receptor Signaling Regulates Adaptive Radioprotection in Glioma Stem Cells

  2013cites this paper
• Investigating the Role of PHIP1 in Breast Cancer

  2013cites this paper
• Selective tyrosine kinase inhibition of insulin‐like growth factor‐1 receptor inhibits human and mouse breast cancer–induced bone cell activity, bone remodeling, and osteolysis

  2013cites this paper
• The metabolic and mitogenic properties of basal insulin analogues

  2013cites this paper
• Hormonally responsive breast cancer cells in a microfluidic co-culture model as a sensor of microenvironmental activity.

  2013cites this paper
• Evaluation of the coordinated actions of estrogen receptors with epidermal growth factor receptor and insulin‐like growth factor receptor in the expression of cell surface heparan sulfate proteoglycans and cell motility in breast cancer cells

  2013cites this paper
• Klotho Acts as a Tumor Suppressor in Cancers

  2013cites this paper
• Mechanisms of Resistance to Radiation

  2013cites this paper
• Combining mTOR Inhibitors with Chemotherapy and Other Targeted Therapies in Advanced Breast Cancer: Rationale, Clinical Experience, and Future Directions

  2013cites this paper
• Genes Dysregulated to Different Extent or Oppositely in Estrogen Receptor-Positive and Estrogen Receptor-Negative Breast Cancers

  2013cites this paper
• Role of IGF-1 receptor in radiation response.

  2012cites this paper
• The scaffold protein MEK Partner 1 is required for the survival of estrogen receptor positive breast cancer cells

  2012cites this paper
• Acción del hexaclorobenceno en la migración, invasión y metástasis en modelos experimentales de cáncer de mama

  2012cites this paper
• Characterisation of the direct antiproliferative effects of a gonadotrophin-releasing hormone analogue

  2012cites this paper
• Novel radiosensitizing anticancer therapeutics.

  2012cites this paper
• Pharmacology and anti-tumor activity of RWJ67657, a novel inhibitor of p38 mitogen activated protein kinase.

  2012cites this paper
• Signaling Pathways in Inflammatory Breast Cancer

  2012cites this paper
• Original Article Pharmacology and anti-tumor activity of RWJ67657, a novel inhibitor of p38 mitogen activated protein kinase

  2012cites this paper
• G a potentiates estrogen receptor o a activity via the ERK signaling pathway

  2012cites this paper
• Gαo potentiates estrogen receptor α activity via the ERK signaling pathway.

  2012cites this paper
• Klotho is a novel biomarker for good survival in resected large cell neuroendocrine carcinoma of the lung.

  2011cites this paper
• Tamoxifen Resistant Breast Cancer and Autophagy

  2011cites this paper
• Activation of c-Src/HER1/STAT5b and HER1/ERK1/2 signaling pathways and cell migration by hexachlorobenzene in MDA-MB-231 human breast cancer cell line.

  2011cites this paper
• Insulin-like growth factor-1 and 17β-estradiol down-regulate prostate apoptosis response-4 expression in MCF-7 breast cancer cells.

  2011cites this paper
• Insulin-like growth factor-dependent proliferation and survival of triple-negative breast cancer cells: implications for therapy.

  2011cites this paper
• Elevated insulin-like growth factor 1 receptor signaling induces antiestrogen resistance through the MAPK/ERK and PI3K/Akt signaling routes

  2011cites this paper
• Divergent effects of insulin-like growth factor-1 receptor expression on prognosis of estrogen receptor positive versus triple negative invasive ductal breast carcinoma

  2011cites this paper
• mTOR inhibition in breast cancer: unraveling the complex mechanisms of mTOR signal transduction and its clinical implications in therapy

  2011cites this paper
• Obesity‐induced metabolic stresses in breast and colon cancer

  2011cites this paper
• PMA-induced up-regulation of TBX3 is mediated by AP-1 and contributes to breast cancer cell migration.

  2011cites this paper
• Activation of cSrc / HER 1 / STAT 5 b and HER 1 / ERK 1 / 2 Signaling Pathways and Cell Migration by Hexachlorobenzene in MDA-MB-231 Human Breast Cancer Cell Line

  2011cites this paper
• Design and development of a peptide-based adiponectin receptor agonist for cancer treatment

  2011cites this paper
• GnRH receptor activation competes at a low level with growth signaling in stably transfected human breast cell lines

  2011influential citation
• The insulin-like growth factor receptor I promotes motility and invasion of bladder cancer cells through Akt- and mitogen-activated protein kinase-dependent activation of paxillin.

  2010cites this paper
• Insulin-like growth factor 1 signalling and its role in cell survival and radiation sensitivity.

  2010cites this paper
• Signal integration through blending, bolstering and bifurcating of intracellular information

  2010cites this paper
• Modulation of the HGF/c-Met/Akt and p38 cell signaling pathways by 3,3'-diindolylmethane in MDA-MB-231 breast cancer cells

  2010cites this paper
• Protein tyrosine phosphatase-1B and T-cell protein tyrosine phosphatase regulate IGF-2-induced MCF-7 cell migration.

  2010cites this paper
• Genetic and Molecular Approaches to Imaging Breast Cancer

  2010cites this paper